| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.093 | 0.06 |